Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edvard Smith

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Seminars in Cancer Biology|November 21, 2016
Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC)C I Edvard Smith
Lakartidningen|January 4, 2018
[Gene therapy – from idea to reality]Edvard Smith, Pontus Blomberg
The FEBS Journal|April 27, 2011
Tec family kinasesLiang Yu, C I Edvard Smith
Annual Review of Pharmacology and Toxicology|October 5, 2018
Therapeutic Oligonucleotides: State of the ArtC I Edvard Smith, Rula Zain
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 18, 2019
Targeted Oligonucleotides for Treating Neurodegenerative Tandem Repeat DiseasesRula Zain, C I Edvard Smith
Expert Opinion on Biological Therapy|August 29, 2003
Gene therapy of monogenic and cardiovascular disordersPontus Blomberg, C I Edvard Smith
Lakartidningen|June 8, 2021
[Gene therapy now enters many clinical disciplines]C I Edvard Smith, Pontus Blomberg
Frontiers in Immunology|June 28, 2021
Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling PathwayC I Edvard Smith, Jan A Burger
Human Vaccines & Immunotherapeutics|February 21, 2014
Safety and efficacy of DNA vaccines: plasmids vs. minicirclesSofia Stenler, Pontus Blomberg, C I Edvard Smith
Human Mutation|September 14, 2006
BTKbase: the mutation database for X-linked agammaglobulinemiaJouni Väliaho, C I Edvard Smith, Mauno Vihinen
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Seminars in Cancer Biology|November 21, 2016
Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC)C I Edvard Smith
Lakartidningen|January 4, 2018
[Gene therapy – from idea to reality]Edvard Smith, Pontus Blomberg
The FEBS Journal|April 27, 2011
Tec family kinasesLiang Yu, C I Edvard Smith
Annual Review of Pharmacology and Toxicology|October 5, 2018
Therapeutic Oligonucleotides: State of the ArtC I Edvard Smith, Rula Zain
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 18, 2019
Targeted Oligonucleotides for Treating Neurodegenerative Tandem Repeat DiseasesRula Zain, C I Edvard Smith
Expert Opinion on Biological Therapy|August 29, 2003
Gene therapy of monogenic and cardiovascular disordersPontus Blomberg, C I Edvard Smith
Lakartidningen|June 8, 2021
[Gene therapy now enters many clinical disciplines]C I Edvard Smith, Pontus Blomberg
Frontiers in Immunology|June 28, 2021
Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling PathwayC I Edvard Smith, Jan A Burger
Human Vaccines & Immunotherapeutics|February 21, 2014
Safety and efficacy of DNA vaccines: plasmids vs. minicirclesSofia Stenler, Pontus Blomberg, C I Edvard Smith
Human Mutation|September 14, 2006
BTKbase: the mutation database for X-linked agammaglobulinemiaJouni Väliaho, C I Edvard Smith, Mauno Vihinen
Pageof 18